Back Refine search Reset
Please choose a search criteria from below
Filters Clear all
Specialties
Treatments

100+ results found in London, UK

Sort by:
Showing 41 - 50 of 100+ results
Oncology
19 years of experience
Clinical Oncology

Dr Asad Qureshi is a Consultant Clinical Oncologist at Guy’s and St Thomas’ NHS Foundation Trust. In his NHS and private practice, he specialises in the treatment of upper and lower gastro-intestinal and non-melanoma skin cancers: Oesophageal Cancer, Stomach Cancer, Colon Cancer, Rectal Cancer, Radiotherapy for non-melanomatous skin cancer, Chemotherapy and SABR. Dr Qureshi is the Clinical Lead for out-patients in the Cancer Centre at Guy’s Hospital, London and is a member of the Senior Oncology Management Team. He is also the Clinical Oncology and Radiotherapy Audit Lead and the Clinical Oncology Oesophago-gastric lead.

He trained at St Bartholomew’s and The Royal London Hospitals medical schools where he gained a BSc in neurosciences. He completed his specialist training in Clinical Oncology at a number of specialist departments in London, including Guy’s and St Thomas’ Hospital, Charing Cross Hospital, St Bartholomew’s Hospital and The Royal Marsden Hospital. During his training spent two years working in the Imaging Sciences Laboratories at Kings College London, and the Centre for Medical Image Computing at University College London assessing novel radiotherapy techniques for the treatment of mobile tumours. Dr Qureshi plays an active role in research and is a Principle Investigator on a number of national clinical trials. His research interests include Stereotactic Radiotherapy (SABR), Image-guided Radiotherapy (IGRT) and dose escalation of radiotherapy and he has published a number of papers in this field.Dr Qureshi is committed to medical education. He is a clinical and educational supervisor for Clinical Oncology trainees at Guy’s and St Thomas’ NHS Foundation Trust. He is also a Medical Supervisor for radiographers on prescribing courses.


Diseases, Medical Tests and Treatments
  • External Beam Radiotherapy (IMRT and IGRT)
  • Chemotherapy
  • Radiotherapy
  • Stereotactic Radiotherapy (Including CyberKnife)
  • Colorectal Cancer
  • Anal Cancer
  • Oesophageal Cancer
  • Gatro-intestinal Cancers
  • Stomach Cancer
Read more
Oncology
17 years of experience
Medical Oncology

Deborah Enting is a Consultant Medical Oncologist at Guy's and St Thomas' NHS Foundation Trust and an Honorary Senior Lecturer at King's College London.

She undertook her medical training at the University of Groningen in The Netherlands and trained in Medical Oncology at Guy's and St George's Hospitals. She was a research fellow at the Department of Immunobiology at King's College London and in collaboration with colleagues of the Translational Oncology Urology Research (TOUR) group at KCL she works on tumour immune surveillance and bladder cancer research.

Deborah is a Medical Oncologist specialising in the treatment of Urological Cancers and the systemic treatment (chemotherapy, immunotherapy and targeted therapies) for bladder, prostate, kidney and testicular cancers. She is a national lead on a number of clinical trials including the IRONMAN prostate cancer registry study.

 


Diseases, Medical Tests and Treatments
  • Bladder cancer
  • Prostate cancer
  • Kidney cancer
  • Testicular cancer
  • Bladder cancer
  • Prostate cancer
  • Kidney cancer
  • Testicular cancer
Read more
Oncology
28 years of experience
Clinical Oncology

Dr Teresa Guerrero Urbano is a Consultant Clinical Oncologist and clinical lead for Radiotherapy at Guy’s and St Thomas’ NHS Foundation Trust and King’s College, London. She is honorary Senior Lecturer at the University of Surrey. Her areas of expertise include: Head & Neck Cancer, Non melanomatous skin cancer and Prostate cancer. Dr Guerrero Urbano has previously held senior Consultant Clinical Oncologist and Honorary Senior Lecturer positions at Royal Surrey County NHS Trust, Basingstoke and North Hampshire NHS Foundation Trust, University of Surrey. She was a Senior Research Fellow at University College London and a Clinical Cancer Research Fellow at the Institute of Cancer Research and Royal Marsden Hospital.

Dr Guerrero Urbano completed her oncology training at the Royal Marsden, Royal Surrey County and Guy’s and St Thomas’ Hospitals. She completed her PhD at the University of London in 2008. Dr Guerrero Urbano is joint Module Leader for the Respiratory, Head and Neck module, MSc in Oncology, Institute of Cancer Research. She offers weekly Oncology Seminars at St Luke’s Cancer Centre aimed at doctors, nurses, radiographers and physicists and monthly lectures at the post-graduate Medical School at the University of Surrey. She is a PhD and MD examiner. Her formal research evaluated technical and biological aspects of intensity-modulated radiotherapy at the Institute of Cancer Research/Royal Marsden Hospital. Dr Guerrero Urbano is particularly interested in the use of novel radiation techniques to minimize long-term side effects and the use of chemotherapy and targeted therapy to improve outcomes. Dr Guerrero Urbano has published her research widely and spoken at conferences worldwide.


Diseases, Medical Tests and Treatments
  • Head and neck cancer
  • Technical and biological aspects of image-guided radiotherapy (IGRT)
  • Intensity-modulated radiotherapy (IMRT)
  • Cancer imaging applied to radiotherapy treatments
  • Head and neck cancer
  • Technical and biological aspects of image-guided radiotherapy (IGRT)
  • Intensity-modulated radiotherapy (IMRT)
  • Cancer imaging applied to radiotherapy treatments
Read more
Oncology
19 years of experience
Medical Oncology

I am a Clinical Reader and Consultant Medical Oncologist at King’s College London and Guy’s and St Thomas’ NHS Foundation Trust. I graduated from University of Oxford in pre-clinical medicine in 1998 and from Imperial College London in Clinical Medicine in 2001. After seven years of training in medicine and oncology I took three years out of my clinical training to carry out a PhD in cancer immunotherapy from King’s College London. My PhD studies were focused on genetically modifying cells for cancer immune therapy with a technique called CAR T Cell therapy. After being awarded my PhD in 2011 I returned to complete my clinical training in medical oncology. I also continued my laboratory research with a Clinical Lecturership from the National Institute for Health Research (NIHR). In 2013 I was awarded a Medical Research Council Clinician Scientist Fellowship to pursue a career at the interface between clinical practice in medical oncology and novel immune therapy research and development. I have published over twenty five peer reviewed papers. 

My research group at King's College London studies approachs to optimise personalised cell-based immune therapies for solid tumour oncology. Through vital collaborations with colleagues at King's and across the UK we are also studying the impact of immune therapies, called checkpoint inhibitor therapies, on human immune responses to help us better understand our remarkable immune systems and develop better ways of predicting, preventing and treating the immune related side effects of these crucial new drugs. 

In my clinical practice I am a medical oncologist with a practice in malignant melanoma and Merkel Cell Carcinoma. I am a principal investigator in the Guy's Cancer Early Phase drug development team where I lead trials of new therapies or combinations in cancer patients. My particular focus is on cancer immune therapies, especially cellular therapies.   I lead for skin cancer research at Guy’s and St Thomas’ NHS Foundation Trust, am our programme director for cell therapies and chair our biological safety committee. 

I belive that quality cancer care is enhanced by bringing together skills in science and clinical practice. To do this well you need to be able to bring new treatments to patients and explain them well. 

I have a young family who take up most of my spare time. And a garden I am more roud of than perhapse I should be! 


.


Diseases, Medical Tests and Treatments
  • Oncolytic viral therapy
  • T-VEC 
  • Malignant melanoma
  • Merkel cell carcinoma
Read more
Oncology
30 years of experience
Medical Oncology

 

Dr Mark Harries is a Consultant Medical Oncologist at Guy's & St Thomas' Hospitals NHS Foundation Trust and honorary senior lecturer at Kings College London School of Medicine - he also sees patients privately. He specialises in the treatment of breast cancer and melanoma.

Dr Harries graduated from Cambridge University and underwent clinical training at the Royal London Hospital. He then trained in medical oncology at the Royal Marsden Hospital and completed a PhD and post-doctoral work in the Department of Immunology at University College, London. His research interests include immunotherapy for melanoma and breast cancer as well as clinical trials of new biological agents for these diseases.

He has published many papers and presents on a regular basis at national and international conferences. He is the Oncology Editor for the International Journal of Clinical Practice. Dr Harries is also an honorary senior lecturer at King's College London School of Medicine. 

It is important that HCA is transparent about our relationship with those doctors who provide us with clinical guidance on delivering the best possible care to patients and operating our hospitals safely and efficiently. We set out here some of the ways in which we work together and the amount we pay this doctor for such services.

 


Diseases, Medical Tests and Treatments
  • Chemotherapy
  • Immunotherapy
  • Biological therapy
  • Hormonal therapy
  • Breast Cancer
  • Melanoma
Read more
Oncology
Recommended by 1 specialist
22 years of experience
Medical Oncology

Dr Kristeleit completed his undergraduate studies at the Universities of Bonn (Germany), Lausanne (Switzerland) and Barts and The London School of Medicine. He has a first class medical degree from Bonn University and performed his post graduate and specialist training in London teaching hospitals. He spent four years as an AVON Clinical Research Fellow at the Breakthrough Breast Cancer Research Centre investigating novel targets in familial breast cancer. He was appointed as a Consultant Medical Oncologist at Guy's and St Thomas' NHS Foundation Trust in 2009.

He has a special interest in breast cancer and Acute Oncology. He provides the medical oncology service for breast cancer at Queen Elizabeth and Queen Mary's hospitals and is currently the lead clinician for Acute Oncology in the South East London Accountable Cancer Network. Dr Kristeleit has a keen research interest in the role of novel therapies for breast cancer. He is an investigator on numerous clinical trials for breast cancer and chairs the oncology research committee at Guy's and St Thomas'.

He gives regular lectures for the University of London and has been invited to speak at national conferences and international meetings. He specializes in the treatment of early and advanced breast cancer.


Diseases, Medical Tests and Treatments

Read more
Dr Stephen Karp

Dr Stephen Karp

1.25 miles

Dr Stephen Karp

1.25 miles
Oncology
41 years of experience
Clinical Oncology

Dr Stephen Karp is a Consultant Clinical Oncologist at North Middlesex Hospital. His preclinical studies were at King’s College London where he also obtained an intercalated BSc in Pharmacology (1st Class Honours). He graduated in Medicine from Westminster Hospital Medical School in 1979 with a distinction in Surgery. His postgraduate training included cardiology at Hammersmith Hospital and neurology at the National Hospital Queen Square as well as general medicine at Whittington Hospital. He was a gastroenterology registrar at Northwick Park Hospital and trained in clinical oncology at the Middlesex Hospital and Mount Vernon Hospital.

Although Dr Karp was trained and initially practised in almost all areas of oncology, he is now specialized in treating cancers of the breast, GI tract (colorectal, oesophagogastric, pancreatic) and urological cancer (prostate and bladder cancer) with chemotherapy, hormone therapy, biological therapy and radiotherapy, including Cyberknife and SABR.


Diseases, Medical Tests and Treatments

  • Breast, gastrointestinal and prostate cancer (chemotherapy and radiotherapy)
  • IMRT IGRT
  • SABR
  • Cyberknife
  • Chemotherapy
  • Hormone therapy
  • Immunotherapy
  • Biological therapy
  • Breast, gastrointestinal and prostate cancer (chemotherapy and radiotherapy)
Read more
Oncology
47 years of experience
Medical Oncology

Agamemnon Epenetos qualified in medicine from Glasgow University, Scotland in 1973 and subsequently specialized in Medical Oncology at St. Bartholomew's Hospital, London where he held an Honorary Consultant appointment in Medical Oncology.

He has been a practicing Oncologist and Cancer Researcher over the last 30 years. He was, until recently, a visiting Professor at Imperial College London. He has published widely on novel cancer therapies and has received much international recognition.

He is interested in giving the best possible cancer treatment combined with the best possible overall holistic care of the patient.

www.agamemnonepenetos.com 


Diseases, Medical Tests and Treatments

Clinical Trials and Cancer Research

Read more
Dr Sherif Raouf

Dr Sherif Raouf

1.25 miles

Dr Sherif Raouf

1.25 miles
Oncology
22 years of experience
Clinical Oncology

Dr Sherif Raouf is a cancer specialist (Consultant Clinical Oncologist) at St Bartholomew's Hospital. After having graduated in 1986, he completed his oncology training at Charing Cross, Mount Vernon and University College London Hospitals. Following that, he took up his current role at Queens Hospital, where since 2005 he has been the lead clinician in colorectal cancers and a key part of the GI team involved in managing up to 350 cancer patients a year.

Dr Raouf is also very experienced in the use of targeted therapies in the treatment of cancers and has pushed for the use of cutting edge technology. One such state of the art radiotherapy machine is called RapidArc (VMAT) which was potentially revolutionary many years ago as it more accurately targets the tumour, reducing the damage to surrounding tissues. Such targeted therapy has been shown to reduce side effects and improve prognoses.

On the research side, Dr Raouf is interested in cancer epidemiology and chemo-radiotherapy in cancer management. Furthermore, he is known globally for his role as a guest lecturer at many conferences worldwide. Consequently, he is currently a Fellow of the Royal College of Radiologists, a member of the European Society for Therapeutic Radiology and Oncology, The American Society of Radiation Oncology and The American Society of Clinical Oncology. Dr Raouf is hence clearly a figure at the top of his field, who is respected by all his peers.


Diseases, Medical Tests and Treatments

  • Biological Therapy
  • Cancer Prevention And Screening
  • Chemotherapy
  • Immunotherapy
  • Neoadjuvant
  • Radiotherapy
  • Targeted Chemo-Radiation Therapy
  • Stereotactic Radiosurgery
  • Adenocarcinoma
  • Bilary Cancer
  • Bowel Cancer
  • Cancer Of Unknown Primary
  • Cervical Cancer
  • Colorectal Cancer
  • Gastro-Intestinal Cancers
  • Gynaecological Cancers
  • Laryngeal Cancer
  • Liver Cancer
  • Lung Cancer
  • Nasal & Sinus Cancer
  • Nasopharyngeal Cancer
  • Neuro-Endocrine Tumours (NETs)
  • Oesophageal Cancer
  • Oral (Mouth) Cancer
  • Ovarian Cancer
  • Palliative Care
  • Pancreatic Cancer
  • Penile Cancer
  • Prostate Cancer
  • Salivary Gland Cancer
  • Stomach Cancer
  • Throat Cancer
  • Urological Cancers
Read more
Oncology
34 years of experience
Clinical Oncology

Dr Stephanie Gibbs graduated from the Royal Free Hospital Medical School in 1986. She trained in Oncology at the Middlesex Hospital, Mount Vernon Hospital, The Royal London Hospital and St Bartholomew's Hospital. She took up a consultant post at BHR Hospitals NHS Trust in 1998 & worked there for over 21 years. 

She specialises in the treatment of urological and breast cancers using radiotherapy and drug therapies including hormone teatments, chemotherapy, targeted therapies and radioisotope treatment. She is trained in the use of advanced radiotherapy techniques including IMRT, IGRT, the use of SpaceOAR Hydrogel for prostate radiotherapy and SABR.

My hobbies are keeping fit, theatre, and dance.


Diseases, Medical Tests and Treatments
  • Urological cancer
  • Breast cancer
  • Chemotherapy
  • Radiotherapy
  • Urological cancers
  • Chemotherapy
  • Radiotherapy
Read more